Sign In

Login

Password

Forgot Password ? Sign Up

Denosumab (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Denosumab" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
14nih.gov
4th place
7th place
8doi.org
2nd place
2nd place
5web.archive.org
1st place
1st place
1landesbioscience.com
low place
low place
1amgen.com
low place
low place
1drugs.com
399th place
214th place
1psu.edu
207th place
408th place
1todaysgeriatricmedicine.com
low place
low place
1urotoday.com
low place
low place
1nytimes.com
7th place
23rd place
1biosciencetechnology.com
low place
low place
1genengnews.com
low place
low place
1medpagetoday.com
9,274th place
9,976th place
1cancer.gov
1,684th place
1,442nd place

amgen.com

biosciencetechnology.com

cancer.gov

doi.org

  • Pageau, Steven C. (2009). “Denosumab”. mAbs. 1 (3): 210–215. doi:10.4161/mabs.1.3.8592. PMC 2726593. PMID 20065634.
  • McClung, Michael R.; Lewiecki, E. Michael; Cohen, Stanley B.; Bolognese, Michael A.; Woodson, Grattan C.; Moffett, Alfred H.; Peacock, Munro; Miller, Paul D.; và đồng nghiệp (2006). “Denosumab in Postmenopausal Women with Low Bone Mineral Density”. N Engl J Med. 354 (8): 821–31. doi:10.1056/NEJMoa044459. PMID 16495394.
  • Lipton, A; Fizazi, K; Stopeck, AT; Henry, DH; Brown, JE; Yardley, DA; Richardson, GE; Siena, S; Maroto, P (tháng 11 năm 2012). “Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials”. EJC (Oxford, England: 1990). 48 (16): 3082–92. doi:10.1016/j.ejca.2012.08.002. PMID 22975218.
  • Josse, R; Khan, A; Ngui, D; Shapiro, M (tháng 3 năm 2013). “Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis”. Current Medical Research and Opinion. 29 (3): 205–16. doi:10.1185/03007995.2013.763779. PMID 23297819.
  • Nayak, S; Greenspan, SL (tháng 3 năm 2017). “Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis”. Journal of the American Geriatrics Society. 65 (3): 490–495. doi:10.1111/jgs.14668. PMC 5358515. PMID 28304090.
  • Cummings, Steven R.; Martin, Javier San; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; và đồng nghiệp (2009). “Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis”. N Engl J Med. 361 (8): 756–65. CiteSeerX 10.1.1.472.3489. doi:10.1056/NEJMoa0809493. PMID 19671655.
  • Khosla, S (2009). “Increasing options for the treatment of osteoporosis”. N Engl J Med. 361 (8): 818–820. doi:10.1056/NEJMe0905480. PMC 3901579. PMID 19671654.
  • Boyce, AM (tháng 8 năm 2017). “Denosumab: an Emerging Therapy in Pediatric Bone Disorders”. Current Osteoporosis Reports. 15 (4): 283–292. doi:10.1007/s11914-017-0380-1. PMC 5554707. PMID 28643220.

drugs.com

  • “Denosumab”. The American Society of Health-System Pharmacists. Truy cập ngày 16 tháng 3 năm 2015.

genengnews.com

landesbioscience.com

  • Pageau, Steven C. (2009). “Denosumab”. mAbs. 1 (3): 210–215. doi:10.4161/mabs.1.3.8592. PMC 2726593. PMID 20065634.

medpagetoday.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Pageau, Steven C. (2009). “Denosumab”. mAbs. 1 (3): 210–215. doi:10.4161/mabs.1.3.8592. PMC 2726593. PMID 20065634.
  • McClung, Michael R.; Lewiecki, E. Michael; Cohen, Stanley B.; Bolognese, Michael A.; Woodson, Grattan C.; Moffett, Alfred H.; Peacock, Munro; Miller, Paul D.; và đồng nghiệp (2006). “Denosumab in Postmenopausal Women with Low Bone Mineral Density”. N Engl J Med. 354 (8): 821–31. doi:10.1056/NEJMoa044459. PMID 16495394.
  • Lipton, A; Fizazi, K; Stopeck, AT; Henry, DH; Brown, JE; Yardley, DA; Richardson, GE; Siena, S; Maroto, P (tháng 11 năm 2012). “Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials”. EJC (Oxford, England: 1990). 48 (16): 3082–92. doi:10.1016/j.ejca.2012.08.002. PMID 22975218.
  • Zhou, Z; Chen, C; Zhang, J; Ji, X; Liu, L; Zhang, G; Cao, X; Wang, P (2014). “Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis”. Int J Clin Exp Pathol. 7 (5): 2113–22. PMC 4069896. PMID 24966919.
  • Josse, R; Khan, A; Ngui, D; Shapiro, M (tháng 3 năm 2013). “Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis”. Current Medical Research and Opinion. 29 (3): 205–16. doi:10.1185/03007995.2013.763779. PMID 23297819.
  • Nayak, S; Greenspan, SL (tháng 3 năm 2017). “Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis”. Journal of the American Geriatrics Society. 65 (3): 490–495. doi:10.1111/jgs.14668. PMC 5358515. PMID 28304090.
  • Cummings, Steven R.; Martin, Javier San; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; và đồng nghiệp (2009). “Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis”. N Engl J Med. 361 (8): 756–65. CiteSeerX 10.1.1.472.3489. doi:10.1056/NEJMoa0809493. PMID 19671655.
  • Khosla, S (2009). “Increasing options for the treatment of osteoporosis”. N Engl J Med. 361 (8): 818–820. doi:10.1056/NEJMe0905480. PMC 3901579. PMID 19671654.
  • Boyce, AM (tháng 8 năm 2017). “Denosumab: an Emerging Therapy in Pediatric Bone Disorders”. Current Osteoporosis Reports. 15 (4): 283–292. doi:10.1007/s11914-017-0380-1. PMC 5554707. PMID 28643220.

ncbi.nlm.nih.gov

  • Pageau, Steven C. (2009). “Denosumab”. mAbs. 1 (3): 210–215. doi:10.4161/mabs.1.3.8592. PMC 2726593. PMID 20065634.
  • Zhou, Z; Chen, C; Zhang, J; Ji, X; Liu, L; Zhang, G; Cao, X; Wang, P (2014). “Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis”. Int J Clin Exp Pathol. 7 (5): 2113–22. PMC 4069896. PMID 24966919.
  • Nayak, S; Greenspan, SL (tháng 3 năm 2017). “Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis”. Journal of the American Geriatrics Society. 65 (3): 490–495. doi:10.1111/jgs.14668. PMC 5358515. PMID 28304090.
  • Khosla, S (2009). “Increasing options for the treatment of osteoporosis”. N Engl J Med. 361 (8): 818–820. doi:10.1056/NEJMe0905480. PMC 3901579. PMID 19671654.
  • Boyce, AM (tháng 8 năm 2017). “Denosumab: an Emerging Therapy in Pediatric Bone Disorders”. Current Osteoporosis Reports. 15 (4): 283–292. doi:10.1007/s11914-017-0380-1. PMC 5554707. PMID 28643220.

nytimes.com

psu.edu

citeseerx.ist.psu.edu

  • Cummings, Steven R.; Martin, Javier San; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; và đồng nghiệp (2009). “Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis”. N Engl J Med. 361 (8): 756–65. CiteSeerX 10.1.1.472.3489. doi:10.1056/NEJMoa0809493. PMID 19671655.

todaysgeriatricmedicine.com

urotoday.com

web.archive.org